Protein Quaternary Structure and Expression Levels Contribute to Peroxisomal-Targeting-Sequence-1-Mediated Peroxisomal Import of Human Soluble Epoxide Hydrolase

Journal of Molecular Biology

Volumn 380, Issue 1, 2008, Pages 31-41

  Luo, Beibei ^a   Norris, Carol ^a   Bolstad, Erin S D ^a   Knecht, David A ^a   Grant, David F ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

peroxisomal targeting sequence; Pex5p; polymorphism; soluble epoxide hydrolase; subcellular localization

Indexed keywords

AMINO ACID; EPOXIDE HYDROLASE; GREEN FLUORESCENT PROTEIN; PROTEIN; PROTEIN SKM;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CELL TRANSPORT; CHO CELL; FEMALE; GENETIC TRANSFECTION; MOLECULAR DYNAMICS; NONHUMAN; OLIGOMERIZATION; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN QUATERNARY STRUCTURE; REGULATORY MECHANISM; TARGET CELL; TISSUE SPECIFICITY; WILD TYPE;

CRICETULUS GRISEUS; MAMMALIA;

EID: 44649141830     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.04.064     Document Type: Article

References (57)

1. Sandberg M., Hassett C., Adman E.T., Meijer J., and Omiecinski C.J. Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J. Biol. Chem. 275 (2000) 28873-28881
2. Cronin A., Mowbray S., Durk H., Homburg S., Fleming I., Fisslthaler B., et al. The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase. Proc. Natl Acad. Sci. USA 100 (2003) 1552-1557
3. Newman J.W., Morisseau C., Harris T.R., and Hammock B.D. The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc. Natl Acad. Sci. USA 100 (2003) 1558-1563
4. Node K., Huo Y., Ruan X., Yang B., Spiecker M., Ley K., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285 (1999) 1276-1279
5. Schmelzer K.R., Kubala L., Newman J.W., Kim I.H., Eiserich J.P., and Hammock B.D. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc. Natl Acad. Sci. USA 102 (2005) 9772-9777
6. Schmelzer K.R., Inceoglu B., Kubala L., Kim I.H., Jinks S.L., Eiserich J.P., and Hammock B.D. Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc. Natl Acad. Sci. USA 103 (2006) 13646-13651
7. Sinal C.J., Miyata M., Tohkin M., Nagata K., Bend J.R., and Gonzalez F.J. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J. Biol. Chem. 275 (2000) 40504-40510
8. Jung O., Brandes R.P., Kim I.H., Schweda F., Schmidt R., Hammock B.D., et al. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension. Hypertension 45 (2005) 759-765
9. Xu D., Li N., He Y., Timofeyev V., Lu L., Tsai H.J., et al. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc. Natl Acad. Sci. USA 103 (2006) 18733-18738
10. Capdevila J.H., Falck J.R., and Harris R.C. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 41 (2000) 163-181
11. Kroetz D.L., and Zeldin D.C. Cytochrome P450 pathways of arachidonic acid metabolism. Curr. Opin. Lipidol. 13 (2002) 273-283
12. Enayetallah A.E., French R.A., Barber M., and Grant D.F. Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues. J. Histochem. Cytochem. 54 (2006) 329-335
13. Fang X., Hu S., Xu B., Snyder G.D., Harmon S., Yao J., et al. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H55-H63
14. Liu Y., Zhang Y., Schmelzer K., Lee T.S., Fang X., Zhu Y., et al. The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase. Proc. Natl Acad. Sci. USA 102 (2005) 16747-16752
15. Spector A.A., and Norris A.W. Action of epoxyeicosatrienoic acids on cellular function. Am. J. Physiol. Cell Physiol. 292 (2007) C996-C1012
16. Edwards P.A., and Ericsson J. Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu. Rev. Biochem. 68 (1999) 157-185
17. Weinhofer I., Kunze M., Stangl H., Porter F.D., and Berger J. Peroxisomal cholesterol biosynthesis and Smith-Lemli-Opitz syndrome. Biochem. Biophys. Res. Commun. 345 (2006) 205-209
18. Holroyd C., and Erdmann R. Protein translocation machineries of peroxisomes. FEBS Lett. 501 (2001) 6-10
19. Gould S.J., Keller G.A., Hosken N., Wilkinson J., and Subramani S. A conserved tripeptide sorts proteins to peroxisomes. J. Cell Biol. 108 (1989) 1657-1664
20. Subramani S., Koller A., and Snyder W.B. Import of peroxisomal matrix and membrane proteins. Annu. Rev. Biochem. 69 (2000) 399-418
21. Swinkels B.W., Gould S.J., Bodnar A.G., Rachubinski R.A., and Subramani S. A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 10 (1991) 3255-32562
22. McCollum D., Monosov E., and Subramani S. The pas8 mutant of Pichia pastoris exhibits the peroxisomal protein import deficiencies of Zellweger syndrome cells-the PAS8 protein binds to the COOH-terminal tripeptide peroxisomal targeting signal, and is a member of the TPR protein family. J. Cell Biol. 121 (1993) 761-774
23. Mullen R.T., Trelease R.N., Duerk H., Arand M., Hammock B.D., Oesch F., and Grant D.F. Differential subcellular localization of endogenous and transfected soluble epoxide hydrolase in mammalian cells: evidence for isozyme variants. FEBS Lett. 445 (1999) 301-305
24. Hayashi M., Aoki M., Kato A., Kondo M., and Nishimura M. Transport of chimeric proteins that contain a carboxy-terminal targeting signal into plant microbodies. Plant J. 10 (1996) 225-234
25. Swinkels B.W., Gould S.J., and Subramani S. Targeting efficiencies of various permutations of the consensus C-terminal tripeptide peroxisomal targeting signal. FEBS Lett. 305 (1992) 133-136
26. Maynard E.L., Gatto Jr. G.J., and Berg J.M. Pex5p binding affinities for canonical and noncanonical PTS1 peptides. Proteins: Struct. Funct. Genet. 55 (2004) 856-861
27. Jansen G.A., Ofman R., Denis S., Ferdinandusse S., Hogenhout E.M., Jakobs C., and Wanders R.J. Phytanoyl-CoA hydroxylase from rat liver. Protein purification and cDNA cloning with implications for the subcellular localization of phytanic acid alpha-oxidation. J. Lipid Res. 40 (1999) 2244-2254
28. Gill S.S., Ota K., and Hammock B.D. Radiometric assays for mammalian epoxide hydrolases and glutathione S-transferase. Anal. Biochem. 131 (1983) 273-282
29. Gatto Jr. G.J., Maynard E.L., Guerrerio A.L., Geisbrecht B.V., Gould S.J., and Berg J.M. Correlating structure and affinity for PEX5:PTS1 complexes. Biochemistry 42 (2003) 1660-1666
30. Srivastava P.K., Sharma V.K., Kalonia D.S., and Grant D.F. Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure. Arch. Biochem. Biophys. 427 (2004) 164-169
31. Wiemer E.A., Nuttley W.M., Bertolaet B.L., Li X., Francke U., Wheelock M.J., et al. Human peroxisomal targeting signal-1 receptor restores peroxisomal protein import in cells from patients with fatal peroxisomal disorders. J. Cell Biol. 130 (1995) 51-65
32. Gomez G.A., Morisseau C., Hammock B.D., and Christianson D.W. Human soluble epoxide hydrolase: structural basis of inhibition by 4-(3-cyclohexylureido)-carboxylic acids. Protein Sci. 15 (2006) 58-64
33. Arand M., Knehr M., Thomas H., Zeller H.D., and Oesch F. An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase. FEBS Lett. 294 (1991) 19-22
34. Brocard C., and Hartig A. Peroxisome targeting signal 1: is it really a simple tripeptide?. Biochim. Biophys. Acta 1763 (2006) 1565-1573
35. Mizuno T., Ito K., Uchida C., Kitagawa M., Ichiyama A., Miura S., et al. Analyses in transfected cells and in vitro of a putative peroxisomal targeting signal of rat liver serine:pyruvate aminotransferase. Histochem. Cell Biol. 118 (2002) 321-328
36. Neuberger G., Maurer-Stroh S., Eisenhaber B., Hartig A., and Eisenhaber F. Motif refinement of the peroxisomal targeting signal 1 and evaluation of taxon-specific differences. J. Mol. Biol. 328 (2003) 567-579
37. Kamigaki A., Mano S., Terauchi K., Nishi Y., Tachibe-Kinoshita Y., Nito K., et al. Identification of peroxisomal targeting signal of pumpkin catalase and the binding analysis with PTS1 receptor. Plant J. 33 (2003) 161-175
38. Waterham H.R., Russell K.A., Vries Y., and Cregg J.M. Peroxisomal targeting, import, and assembly of alcohol oxidase in Pichia pastoris. J. Cell Biol. 139 (1997) 1419-1431
39. Stewart M.Q., Esposito R.D., Gowani J., and Goodman J.M. Alcohol oxidase and dihydroxyacetone synthase, the abundant peroxisomal proteins of methylotrophic yeasts, assemble in different cellular compartments. J. Cell Sci. 114 (2001) 2863-2868
40. Leon S., Goodman J.M., and Subramani S. Uniqueness of the mechanism of protein import into the peroxisome matrix: transport of folded, co-factor-bound and oligomeric proteins by shuttling receptors. Biochim. Biophys. Acta 1763 (2006) 1552-1564
41. McNew J.A., and Goodman J.M. An oligomeric protein is imported into peroxisomes in vivo. J. Cell Biol. 127 (1994) 1245-1257
42. Titorenko V.I., Nicaud J.M., Wang H., Chan H., and Rachubinski R.A. Acyl-CoA oxidase is imported as a heteropentameric, cofactor-containing complex into peroxisomes of Yarrowia lipolytica. J. Cell Biol. 156 (2002) 481-494
43. Crookes W.J., and Olsen L.J. The effects of chaperones and the influence of protein assembly on peroxisomal protein import. J. Biol. Chem. 273 (1998) 17236-17242
44. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, Palo Alto, CA, USA
45. Van Ael E., and Fransen M. Targeting signals in peroxisomal membrane proteins. Biochim. Biophys. Acta 1763 (2006) 1629-1638
46. Oda T., Uchida C., and Miura S. Mitochondrial targeting signal-induced conformational change and repression of the peroxisomal targeting signal of the precursor for rat liver serine:pyruvate/alanine:glyoxylate aminotransferase. J. Biochem. (Tokyo) 127 (2000) 665-671
47. Petrova V.Y., Drescher D., Kujumdzieva A.V., and Schmitt M.J. Dual targeting of yeast catalase A to peroxisomes and mitochondria. Biochem. J. 380 (2004) 393-400
48. Przybyla-Zawislak B.D., Srivastava P.K., Vazquez-Matias J., Mohrenweiser H.W., Maxwell J.E., Hammock B.D., et al. Polymorphisms in human soluble epoxide hydrolase. Mol. Pharmacol. 64 (2003) 482-490
49. Enayetallah A.E., and Grant D.F. Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis. Biochem. Biophys. Res. Commun. 341 (2006) 254-260
50. Fornage M., Lee C.R., Doris P.A., Bray M.S., Heiss G., Zeldin D.C., and Boerwinkle E. The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke. Hum. Mol. Genet. 14 (2005) 2829-2837
51. Lee C.R., North K.E., Bray M.S., Fornage M., Seubert J.M., Newman J.W., et al. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Hum. Mol. Genet. 15 (2006) 1640-1649
52. Fornage M., Boerwinkle E., Doris P.A., Jacobs D., Liu K., and Wong N.D. Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation 109 (2004) 335-339
53. Sato K., Emi M., Ezura Y., Fujita Y., Takada D., Ishigami T., et al. Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred. J. Hum. Genet. 49 (2004) 29-34
54. Ohtoshi K., Kaneto H., Node K., Nakamura Y., Shiraiwa T., Matsuhisa M., and Yamasaki Y. Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients. Biochem. Biophys. Res. Commun. 331 (2005) 347-350
55. Wei Q., Doris P.A., Pollizotto M.V., Boerwinkle E., Jacobs D.R., Siscovick Jr. D.S., and Fornage M. Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking. Atherosclerosis 190 (2007) 26-34
56. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., et al. The Protein Data Bank. Nucleic Acids Res. 28 (2000) 235-242
57. Gatto Jr. G.J., Geisbrecht B.V., Gould S.J., and Berg J.M. Peroxisomal targeting signal-1 recognition by the TPR domains of human PEX5. Nat. Struct. Biol. 7 (2000) 1091-1095